BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 9064487)

  • 1. The nonspecificity of focal segmental glomerulosclerosis. The defining characteristics of primary focal glomerulosclerosis, mesangial proliferation, and minimal change.
    McAdams AJ; Valentini RP; Welch TR
    Medicine (Baltimore); 1997 Jan; 76(1):42-52. PubMed ID: 9064487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electron microscopic findings suggestive of focal and segmental glomerulosclerosis in patients with steroid-resistant nephrotic syndrome.
    Nili F; Saboori F; Jahanzad I; Mehrazma M
    Ultrastruct Pathol; 2019; 43(1):6-12. PubMed ID: 30835594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IgM nephropathy: is it closer to minimal change disease or to focal segmental glomerulosclerosis?
    Brugnano R; Del Sordo R; Covarelli C; Gnappi E; Pasquali S
    J Nephrol; 2016 Aug; 29(4):479-86. PubMed ID: 26842624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A quantitative analysis of the glomeruli in focal segmental glomerulosclerosis.
    Suzuki J; Yoshikawa N; Nakamura H
    Pediatr Nephrol; 1994 Aug; 8(4):416-9. PubMed ID: 7947029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of IgM and C1q deposition in the mesangium in pediatric idiopathic nephrotic syndrome.
    Kanemoto K; Ito H; Anzai M; Matsumura C; Kurayama H
    J Nephrol; 2013; 26(2):306-14. PubMed ID: 22641570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Glomerular kidney diseases that are associated with a large clinical proteinuria and/or nephrotic syndrome].
    Danilewicz M
    Pol J Pathol; 2011 Jun; 62(2 Suppl 1):s32-40. PubMed ID: 23120829
    [No Abstract]   [Full Text] [Related]  

  • 7. C1q nephropathy: a variant of focal segmental glomerulosclerosis.
    Markowitz GS; Schwimmer JA; Stokes MB; Nasr S; Seigle RL; Valeri AM; D'Agati VD
    Kidney Int; 2003 Oct; 64(4):1232-40. PubMed ID: 12969141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathology of nephrotic syndrome with minimal or minor glomerular changes.
    Grishman E; Churg J
    Perspect Nephrol Hypertens; 1973; 1 Pt 1():165-81. PubMed ID: 4536421
    [No Abstract]   [Full Text] [Related]  

  • 9. Pathology, clinical presentations, and outcomes of C1q nephropathy.
    Vizjak A; Ferluga D; Rozic M; Hvala A; Lindic J; Levart TK; Jurcić V; Jennette JC
    J Am Soc Nephrol; 2008 Nov; 19(11):2237-44. PubMed ID: 18650484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultrastructure of the non-sclerotic glomeruli in childhood nephrotic syndrome.
    Yoshikawa N; Cameron AH; White RH
    J Pathol; 1982 Feb; 136(2):133-47. PubMed ID: 7199568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nephrotic syndrome associated with diffuse mesangial hypercellularity: is it a heterogeneous disease entity?
    Joh K; Matsuyama N; Kanetsuna Y; Usui N; Hattori M; Yumura W; Aizawa S
    Am J Nephrol; 1998; 18(3):214-20. PubMed ID: 9627037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glomerular C4d deposition can precede the development of focal segmental glomerulosclerosis.
    van de Lest NA; Zandbergen M; Wolterbeek R; Kreutz R; Trouw LA; Dorresteijn EM; Bruijn JA; Bajema IM; Scharpfenecker M; Chua JS
    Kidney Int; 2019 Sep; 96(3):738-749. PubMed ID: 31327475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pure mesangial proliferative glomerulonephritis. A clinicomorphologic analysis and its possible role in morphologic transition of minimal change lesion.
    Andal A; Saxena S; Chellani HK; Sharma S
    Nephron; 1989; 51(3):314-9. PubMed ID: 2918942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glomerular volume and renal function in children with different types of the nephrotic syndrome.
    Nyberg E; Bohman SO; Berg U
    Pediatr Nephrol; 1994 Jun; 8(3):285-9. PubMed ID: 7917852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changing etiologies of unexplained adult nephrotic syndrome: a comparison of renal biopsy findings from 1976-1979 and 1995-1997.
    Haas M; Meehan SM; Karrison TG; Spargo BH
    Am J Kidney Dis; 1997 Nov; 30(5):621-31. PubMed ID: 9370176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Nephrotic syndrom with focal and segmental glomerulosclerosis in Dakar: epidemiological and clinicopathological characteristics (about 134 cases)].
    Niang A; Dial C; Ka EF; Lèye A; Pouye A; Ka MM; Mbengue M; Droz D; Diouf B
    Dakar Med; 2008; 53(1):45-51. PubMed ID: 19102117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural antibody and complement activation characterize patients with idiopathic nephrotic syndrome.
    Trachtman H; Laskowski J; Lee C; Renner B; Feemster A; Parikh S; Panzer SE; Zhong W; Cravedi P; Cantarelli C; Kulik L; You Z; Satchell S; Rovin B; Liu F; Kalled SL; Holers VM; Jalal D; Thurman JM
    Am J Physiol Renal Physiol; 2021 Oct; 321(4):F505-F516. PubMed ID: 34459222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Histological classification of chronic glomerular diseases].
    Noël LH; Gubler MC
    Rev Prat; 2003 Nov; 53(18):2005-12. PubMed ID: 15008214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinguishing minimal-change disease from mesangial disorders.
    Border WA
    Kidney Int; 1988 Sep; 34(3):419-34. PubMed ID: 3050250
    [No Abstract]   [Full Text] [Related]  

  • 20. IgM nephropathy in India: a single centre experience.
    Vanikar AV; Kanodia KV; Patel RD; Suthar KS; Patel HV; Gumber MR; Trivedi HL
    Indian J Pediatr; 2012 Aug; 79(8):1025-7. PubMed ID: 22290630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.